For immediate release
Date: 14 November 2016
BloodworksNW welcomes BenTech
Expands Products and Services for Research Institutions
SEATTLE, WA – Bloodworks Northwest has announced its acquisition of BenTech Biotechnology Services (BenTech) – expanding and enhancing the range of products and services it provides to medical research and biotech institutions of all sizes – from small startups to Fortune 500 companies.
Founded in 2005, BenTech services include donor recruitment and program management, blood collection, specialized cell processing and selection, frozen cell banking, and execution of customized protocols for research purposes. BenTech also offers consulting services.
“We are pleased to welcome BenTech into the Bloodworks family,” said James P. AuBuchon, MD, president and CEO of Bloodworks. “By coming together, both organizations are strengthened.”
“This partnership deepens our relationship with other institutions involved in medical research,” AuBuchon noted. “There is real synergy with our broader focus on advancing cellular technologies and therapies to support the highest level of healthcare possible.”
Jill Benson, president of BenTech, said: “Tapping into the capacity and expertise of Bloodworks enables us to expand the specialized cell isolation and processing services we provide to research institutions and scientists involved in biomedical studies. We will offer even greater value and opportunity for our clients.” The transition of BenTech employees and clients to Bloodworks will be completed by yearend.
Bloodworks (formerly Puget Sound Blood Center) is backed by 70 years of Northwest history and 250,000 donors. We are local, nonprofit, independent, volunteer-supported and community-based. A recognized leader in transfusion medicine, Bloodworks serves patients in more than 90 hospitals in Washington, Oregon and Alaska — partnering closely with local hospitals to deliver the highest level of patient care. Comprehensive services include blood components, complex cross-matching, specialized lab services for organ transplants, care for patients with blood disorders, and collection of cord blood stem cells for cancer treatment. We’re one of the few blood centers in the U.S. doing leading-edge research on blood biology, transfusion and blood disorders. Patients with traumatic injuries, undergoing surgeries or organ transplantation, or receiving treatment for cancer and blood disorders all depend on our services, expertise, laboratories and research. For more information, visit bloodworksnw.org.